Janneke van den Bent - Manager, SKIM - Janneke is a manager at SKIM with an educational background in Anthropology and Business Administration. She has one big regret in life: Not choosing to study medicine instead. Healthcare market research is thus the perfect intersection of her interests & her educational background. Through the years, she’s come to realize that her heart lies in patient research and she’s been a part of many patient experience studies using both traditional and novel research methodologies across indications.  

Carolyn Chamberlain - Blueprint Partnership - With a track record of more than 20+ years of experience in pharmaceutical market research, both client and agency side, working in a variety of roles. 

Her career began at AstraZeneca Global where she led insights teams within CV and Oncology for over a decade. Her contributions helped drive the growth of key blockbusters. Carolyn is a well-known commercial market leader in qualitative and quantitative insight in both the UK and overseas. She is passionate about engaging with a diverse range of stakeholders and driving debate in our industry. We must continue to positively disrupt and transform our industry! 

Over the last 15 years, she has held senior commercial and leadership positions whilst also being a key contributor to EphMRA, PMRC and the BHBIA. 

Mark Waker - MTW Consultancy - Mark is managing director of a market access consultancy, MTW Consultancy Ltd, specialising in advising small to medium sized pharmaceutical companies as well as governments on integrated pricing, reimbursement, access and health economic solutions to healthcare delivery. Mark has over twenty years’ industry experience working in a broad range of therapeutic areas with exposure to all stages of the product life cycle. Working with payers and market access stakeholders, projects undertaken range from early asset pipeline assessments through to LOE and life-cycle management access strategies. Mark also specialises in advising companies on how to optimally integrate and structure market access capabilities within their organisations. 

Mark started off his career at Procter & Gamble then held marketing and market access roles at Merck and Nycomed before setting up his own consultancy in 2010.